HRTX icon

Heron Therapeutics
HRTX

Overview Fund Activity

92 hedge funds and large institutions have $848M invested in Heron Therapeutics in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 46 increasing their positions, 24 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
-7
Holders Change %
-7.07%
% of All Funds
2.46%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
7
Increased
46
Reduced
24
Closed
13
Calls
$13.6M
Puts
$6.25M
Net Calls
+$7.36M
Net Calls Change
+$1.82M

Top Buyers

1
TCM
1
Tang Capital Management
California
$112M
2
JHIU
2
Janus Henderson Investors US
Colorado
$72.5M
3
KCM
3
Kingdon Capital Management
New York
$16.4M
4
PHS
4
PFM Health Sciences
California
$60.5M
5
TCM
5
Tekla Capital Management
Massachusetts
$8.89M

Top Sellers

1
Allianz Asset Management
1
Allianz Asset Management
Germany
$3.88M
2
Invesco
2
Invesco
Georgia
$52.5M
3
BC
3
Broadfin Capital
New York
$22.6M
4
State Street
4
State Street
Massachusetts
$17.9M
5
Goldman Sachs
5
Goldman Sachs
New York
$152K
Name Holding Trade Value Shares
Change 		Shares
Change %
PCM
101
Prelude Capital Management
New York
– -$90K -4,747 Closed
Parallax Volatility Advisers
102
Parallax Volatility Advisers
California
– -$11K -599 Closed
1 2 3 4
5